Breast Cancer 2012 - New Aspects.

ABSTRACT: Treatment options as well as the characteristics for therapeutic decisions in patients with primary and advanced breast cancer are increasing in number and variety. New targeted therapies in combination with established chemotherapy schemes are broadening the spectrum, however potentially promising combinations do not always achieve a better result. New data from the field of pharmacogenomics point to prognostic and predictive factors that take not only the properties of the tumour but also inherited genetic properties of the patient into consideration. Current therapeutic decision-making is thus based on a combination of classical clinical and modern molecular biomarkers. Also health-economic aspects are more frequently being taken into consideration so that health-economic considerations

SUBMITTER: Kolberg HC 

PROVIDER: S-EPMC4168404 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature